The US Food and Drug Administration (FDA) and CDC (Centers for Disease Control and Prevention) are looking into 4 complaints about illness linked to Abbott Nutrition formula produced in a Michigan factory.
The US Food and Drug Administration has started an inspection of the Sturgis, Michigan Abbott Nutrition plant that manufactured powedered infant formula that has been linked to 3 reports of Cronobacter sakazakii infections and 1 report of Salmonella Newport infection in infants.1 All of the infants required hospitalization and 1 died.
The findings found so far include multiple positive C sakazakii results from samples. A review of records showed potential environmental contamination from C sakazakii as well as product that had been destroyed because of the presence of the bacteria.
Abbott Nutrition started a voluntary recall of the formula yesterday, February 17, 2022. The affected products are Similac, Alimentum, or EleCare with the following information that can be found on the bottom:
This article was published by our sister publication Contemporary Pediatrics.
Reference
1. US Food and Drug Administration. FDA investigation of Cronobacter and Salmonella complaints: powdered infant formula. Published February 18, 2022. Accessed February 18, 2022. https://www.fda.gov/food/outbreaks-foodborne-illness/fda-investigation-cronobacter-and-salmonella-complaints-powdered-infant-formula-february-2022
Link between infertility and autism spectrum disorder risk
December 6th 2023New research uncovers a connection between infertility and autism spectrum disorder risk, prompting a closer look at perinatal influences and the potential impact of fertility treatments on the developmental trajectory of children.
Read More
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More
Late-preterm antenatal corticosteroid treatment in twin pregnancies and newborn morbidity
November 27th 2023A recent retrospective cohort study found that administering antenatal corticosteroids from 34 to 36 weeks of gestation did not decrease composite neonatal respiratory morbidity in twin pregnancies, challenging conventional practices for this high-risk population.
Read More
The impact of WIC enrollment on breastfeeding rates: A comprehensive study
November 21st 2023Explore the findings of a recent study, revealing that enrollment in the Special Supplemental Nutritional Program for Women, Infants, and Children may influence breastfeeding decisions, shedding light on disparities and suggesting the need for targeted initiatives to enhance breastfeeding rates among low-income mothers.
Read More